WallStreetZenWallStreetZen

NASDAQ: CRON
Cronos Group Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CRON past revenue growth

How has CRON's revenue growth performed historically?
Company
0.57%
Industry
10.18%
Market
17.2%
CRON's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CRON's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CRON's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CRON earnings and revenue history

Current Revenue
$87.2M
Current Earnings
-$74.0M
Current Profit Margin
-84.8%

CRON Return on Equity

Current Company
-6.6%
Current Industry
15.4%
Current Market
188%
CRON's Return on Equity (-6.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CRON announces earnings.

CRON Return on Assets

Current Company
-6.4%
Current Industry
3.4%
CRON is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CRON Return on Capital Employed

Current Company
-11.69%
Current Industry
5.1%
CRON's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRON vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CRON$87.24M-$120.32M-$73.96M+48.40%N/A
CGC$246.67M-$907.84M-$952.65M+16.69%N/A
COLL$566.77M$308.33M$48.16M+15.11%+94.10%
DCPH$163.36M-$187.94M-$194.94M+59.88%N/A
PCRX$674.98M$157.58M$41.96M+14.88%-90.17%
View Top Pharmaceutical Stocks

CRON earnings dates

Next earnings date
Jun 20, 2024

Cronos Group Earnings & Revenue FAQ

What were CRON's earnings last quarter?

On Invalid Date, Cronos Group (NASDAQ: CRON) reported Q4 2023 earnings per share (EPS) of -$0.11, up 47.62% year over year. Total Cronos Group earnings for the quarter were -$44.79 million. In the same quarter last year, Cronos Group's earnings per share (EPS) was -$0.21.

If you're new to stock investing, here's how to buy Cronos Group stock.

What was CRON's earnings growth in the past year?

As of Q2 2024, Cronos Group's earnings has grown year over year. Cronos Group's earnings in the past year totalled -$73.96 million.

What is CRON's earnings date?

Cronos Group's earnings date is Invalid Date. Add CRON to your watchlist to be reminded of CRON's next earnings announcement.

What was CRON's revenue last quarter?

On Invalid Date, Cronos Group (NASDAQ: CRON) reported Q4 2023 revenue of $23.92 million up 8.54% year over year. In the same quarter last year, Cronos Group's revenue was $22.03 million.

What was CRON's revenue growth in the past year?

As of Q2 2024, Cronos Group's revenue has grown 0.57% year over year. This is 9.62 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.18%. Cronos Group's revenue in the past year totalled $87.24 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.